Follow
Anne-Marie Mes-Masson
Anne-Marie Mes-Masson
Professor, Departement of Medicine, Université de Montréal
Verified email at umontreal.ca
Title
Cited by
Cited by
Year
The immune landscape of cancer
V Thorsson, DL Gibbs, SD Brown, D Wolf, DS Bortone, THO Yang, ...
Immunity 48 (4), 812-830. e14, 2018
44922018
An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics
J Liu, T Lichtenberg, KA Hoadley, LM Poisson, AJ Lazar, AD Cherniack, ...
Cell 173 (2), 400-416. e11, 2018
26592018
The molecular taxonomy of primary prostate cancer
A Abeshouse, J Ahn, R Akbani, A Ally, S Amin, CD Andry, M Annala, ...
Cell 163 (4), 1011-1025, 2015
26262015
Oncogenic signaling pathways in the cancer genome atlas
F Sanchez-Vega, M Mina, J Armenia, WK Chatila, A Luna, KC La, ...
Cell 173 (2), 321-337. e10, 2018
25052018
Comprehensive characterization of cancer driver genes and mutations
MH Bailey, C Tokheim, E Porta-Pardo, S Sengupta, D Bertrand, ...
Cell 173 (2), 371-385. e18, 2018
22002018
Cell-of-origin patterns dominate the molecular classification of 10,000 tumors from 33 types of cancer
KA Hoadley, C Yau, T Hinoue, DM Wolf, AJ Lazar, E Drill, R Shen, ...
Cell 173 (2), 291-304. e6, 2018
20562018
ARID1A mutations in endometriosis-associated ovarian carcinomas
KC Wiegand, SP Shah, OM Al-Agha, Y Zhao, K Tse, T Zeng, J Senz, ...
New England Journal of Medicine 363 (16), 1532-1543, 2010
19162010
Machine learning identifies stemness features associated with oncogenic dedifferentiation
TM Malta, A Sokolov, AJ Gentles, T Burzykowski, L Poisson, JN Weinstein, ...
Cell 173 (2), 338-354. e15, 2018
16162018
Cancer risks in BRCA2 mutation carriers
Breast Cancer Linkage Consortium
Journal of the National Cancer Institute 91 (15), 1310-1316, 1999
12971999
The chronic myelogenous leukemia-specific P210 protein is the product of the bcr/abl hybrid gene
Y Ben-Neriah, GQ Daley, AM Mes-Masson, ON Witte, D Baltimore
Science 233 (4760), 212-214, 1986
10551986
Genomic and molecular landscape of DNA damage repair deficiency across the cancer genome atlas
TA Knijnenburg, L Wang, MT Zimmermann, N Chambwe, GF Gao, ...
Cell reports 23 (1), 239-254. e6, 2018
9242018
Genomic and functional approaches to understanding cancer aneuploidy
AM Taylor, J Shih, G Ha, GF Gao, X Zhang, AC Berger, SE Schumacher, ...
Cancer cell 33 (4), 676-689. e3, 2018
8842018
Oral contraceptives and the risk of hereditary ovarian cancer
SA Narod, H Risch, R Moslehi, A Dørum, S Neuhausen, H Olsson, ...
New England Journal of Medicine 339 (7), 424-428, 1998
8671998
Mutation of FOXL2 in granulosa-cell tumors of the ovary
SP Shah, M Köbel, J Senz, RD Morin, BA Clarke, KC Wiegand, G Leung, ...
New England Journal of Medicine 360 (26), 2719-2729, 2009
8602009
Spatial organization and molecular correlation of tumor-infiltrating lymphocytes using deep learning on pathology images
J Saltz, R Gupta, L Hou, T Kurc, P Singh, V Nguyen, D Samaras, ...
Cell reports 23 (1), 181-193. e7, 2018
8442018
The cancer genome atlas comprehensive molecular characterization of renal cell carcinoma
CJ Ricketts, AA De Cubas, H Fan, CC Smith, M Lang, E Reznik, R Bowlby, ...
Cell reports 23 (1), 313-326. e5, 2018
8392018
Comprehensive analysis of alternative splicing across tumors from 8,705 patients
A Kahles, KV Lehmann, NC Toussaint, M Hüser, SG Stark, ...
Cancer cell 34 (2), 211-224. e6, 2018
7252018
Pathogenic germline variants in 10,389 adult cancers
K Huang, RJ Mashl, Y Wu, DI Ritter, J Wang, C Oh, M Paczkowska, ...
Cell 173 (2), 355-370. e14, 2018
7252018
Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study
SA Narod, JS Brunet, P Ghadirian, M Robson, K Heimdal, SL Neuhausen, ...
The Lancet 356 (9245), 1876-1881, 2000
6792000
Scalable open science approach for mutation calling of tumor exomes using multiple genomic pipelines
K Ellrott, MH Bailey, G Saksena, KR Covington, C Kandoth, C Stewart, ...
Cell systems 6 (3), 271-281. e7, 2018
6452018
The system can't perform the operation now. Try again later.
Articles 1–20